Literature DB >> 7517695

Expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on proliferating vascular endothelial cells in diabetic epiretinal membranes.

S Tang1, K C Le-Ruppert, V P Gabel.   

Abstract

The present study demonstrated the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), the proliferating status of the neovascular endothelial cells, and the activation of vascular endothelial cells bearing the two cell adhesion molecules in diabetic epiretinal membranes by using double immunofluorescence and APAAP techniques. The results showed that ICAM-1 was detected in 36 out of 40 (90%) proliferative diabetic retinopathy epiretinal membranes, VCAM-1 was found in 32 out of 40 cases (80%); in 21 out of 26 (81%) vascularised membranes the endothelial cells of the new vessels in the membranes were still in a proliferative stage (positive for proliferating endothelial cell marker EN 7/44) and, further, in 20 out of 26 cases (77%) ICAM-1 was detected on the proliferating endothelial cells and VCAM-1 was found in 21 cases (81%). The expression of cell adhesion molecules, especially ICAM-1 and VCAM-1 in diabetic epiretinal membranes suggests that cell to cell interactions may play a significant role in the development of PDR membranes. In particular, the expression of ICAM-1 and VCAM-1 on proliferating endothelial cells indicates the activation of these cells, which is the first critical step for lymphocyte/endothelial cell interactions and the initiation of immune responses. The significance of proliferating status of the neovascularisation in the membranes may be related to the clinical course and prognosis of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517695      PMCID: PMC504790          DOI: 10.1136/bjo.78.5.370

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  38 in total

1.  A histopathologic review of 168 cases of preretinal membrane.

Authors:  J G Clarkson; W R Green; D Massof
Journal:  Am J Ophthalmol       Date:  1977-07       Impact factor: 5.258

2.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.

Authors:  A H Stolpen; E C Guinan; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

3.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

Authors:  M L Dustin; R Rothlein; A K Bhan; C A Dinarello; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  Endothelial fenestrae in proliferative diabetic retinopathy.

Authors:  I H Wallow; P S Geldner
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-10       Impact factor: 4.799

5.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

6.  Ocular deposits of immunoglobulin in diabetic retinopathy.

Authors:  M Melato; G Antonutto; R Manconi; E Ponte
Journal:  Can J Ophthalmol       Date:  1982-02       Impact factor: 1.882

7.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

8.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.

Authors:  R Rothlein; M L Dustin; S D Marlin; T A Springer
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  Diabetic preretinal membranes. An immunohistochemical study.

Authors:  J A Jerdan; R G Michels; B M Glaser
Journal:  Arch Ophthalmol       Date:  1986-02

10.  A transmission and scanning electron microscopic study of surgically excised preretinal membrane proliferations in diabetes mellitus.

Authors:  C W Hamilton; D Chandler; G K Klintworth; R Machemer
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

View more
  11 in total

1.  Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat.

Authors:  W Y Shen; M J Yu; C J Barry; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy.

Authors:  G A Limb; A H Chignell; W Green; F LeRoy; D C Dumonde
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

Review 3.  Molecular imaging of retinal disease.

Authors:  Megan E Capozzi; Andrew Y Gordon; John S Penn; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

4.  Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory.

Authors:  Pooi-See Chan; Mamta Kanwar; Renu A Kowluru
Journal:  J Diabetes Complications       Date:  2008-12-03       Impact factor: 2.852

5.  Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy.

Authors:  S Tang; K C Le-Ruppert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

6.  Plasma E-selectin levels can play a role in the development of diabetic retinopathy.

Authors:  Márta Kasza; J Meleg; J Vardai; B Nagy; E Szalai; J Damjanovich; A Csutak; B Ujhelyi; V Nagy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

7.  Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients.

Authors:  A W Stitt; T A Gardiner; D B Archer
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

8.  Continuous Formation of Ultrathin, Strong Collagen Sheets with Tunable Anisotropy and Compaction.

Authors:  Shashi Malladi; David Miranda-Nieves; Lian Leng; Stephanie J Grainger; Constantine Tarabanis; Alexander P Nesmith; Revanth Kosaraju; Carolyn A Haller; Kevin Kit Parker; Elliot L Chaikof; Axel Günther
Journal:  ACS Biomater Sci Eng       Date:  2020-05-26

9.  MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy.

Authors:  Yang Wang; Hua Yan
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

10.  Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3'-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression.

Authors:  Arijit Bhowmik; Sayak Chakravarti; Aparajita Ghosh; Rajni Shaw; Suman Bhandary; Satyaranjan Bhattacharyya; Parimal C Sen; Mrinal K Ghosh
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.